AlphaValue has moved a recommendation for Lloyds Banking Group from “add” to “sell” and say that short term valuation approaches are detrimental to the stock valuation due to Lloyd’s recovery profile. AlphaValue’s target price for Lloyds is currently 81p.
Standard & Poor’s (S&P) Equity Research has called Nobel Biocare’s stocks underperforming and overbought and has downgraded to “strong sell” from “sell”. S&P says it continues to believe revenue growth must return for the share to perform despite some recent cost-cutting initiatives.
Numis Securities believes that moneysupermarket.com is attractive to investors on a number of levels: i) short term value, ii) exposed to medium term financial services recovery and iii) long term growth. Numis has issued a “buy” rating for moneysupermarket.com.